Monthly Archives: March 2019

Specialty Entertainment Expands Phoenix-based Event Booking Agency’s Offering

Unique specialty entertainment roster bolsters Arizona-based event booking company’s offering to clientele in local, national and international markets.

Phoenix, United States – March 27, 2019 /PressCable/

Onstage Entertainment Group, LLC., a Phoenix, Arizona based entertainment booking agency has expanded its offering to provide a wider range of entertainment options for clients in the greater Phoenix area and beyond.

Known for providing talent to top-tier resorts, venues, restaurants and country clubs, as well as for event planners, destination management companies, and corporate clientele and weddings, the move toward booking a broader range of talent was a natural one.

“Since Onstage Entertainment Group was formed, we’ve focused on a wide variety of entertainment, but our mainstay has leaned toward musicians and bands,“ said Joe Costello, Founder, Onstage Entertainment Group. “In recent years we’ve found a steady uptick in interest for unique private and corporate event talent and have responded to that interest.”

Onstage Entertainment Group now boasts both a world-class roster of musicians and bands as well as a diverse offering of interactive, specialty entertainment options including:

– A-List entertainment

– Aerial performers and circus acts

– Comedians

– DJ’s and emcees

– Magicians, mentalists and illusionists

– Professional speakers

– Solo, duo and trio musical acts

– Tribute/cover bands, jazz ensembles, big bands

With a strong presence in the Phoenix, AZ market, talent is provided in the greater Phoenix metropolitan area as well as the surrounding communities of Scottsdale, Paradise Valley, Mesa and Tempe. A-list musicians, bands, speakers and speciality performers are sourced locally, nationally and internationally, and booked for events worldwide.

Specialty performers have most often, but not exclusively, been in demand by corporate event planners and destination management companies. Their availability, however, is for anyone planning to host any type of event, including, but not limited to:

– Corporate Events

– Festivals

– Private Parties

– Weddings

Onstage Entertainment Group is a member of the International Live Events Association and National Association of Catering Executives representing and booking event talent locally, regionally and internationally. To learn more about Onstage Entertainment Group’s event talent booking, services and management, visit the Onstage Entertainment Group’s website (osegllc.com) or call (480) 681-0444.

Contact Info:
Name: Joe Costello
Organization: Onstage Entertainment
Address: 4222 E. Thomas Road Suite 350 B, Phoenix, AZ 85018, United States
Phone: +1-480-681-0444
Website: https://osegllc.com

Source: PressCable

Release ID: 495424

Vacationing Overseas Easy Preparation Tips Expert Advice Report Launched

Travel expert Andrew M. Berke launched a new report featuring the three essential tips to enjoy a safe and fulfilling overseas vacation.

Apollo Beach, United States – March 27, 2019 /PressCable/

Experienced traveler Andrew M. Berke launched a new report featuring three essential tips for effective overseas vacation planning. Based on Andrew’s extensive experience traveling throughout the world, the tips can prevent potentially problematic situations such as getting lost or missing flights, and help travelers enjoy a happy, satisfying overseas experience.

The full report can be found at http://andrew-m-berke.com.

Vacationing overseas for the first time can be a challenging experience requiring adequate planning. While the prospect of sitting down with a long to-do list can be daunting for many tourists, a few basic steps can be enough to significantly reduce the risk of unpleasant experiences and enjoy a safe and fulfilling vacation.

The first tip Andrew suggests is finding a reliable offline replacement for Google maps and other navigation apps which require mobile data plans, since standard mobile plans may not support international roaming without large extra costs.

According to the report, “to work around this, you can use fold-out maps or download mobile phone apps. Some travel experts suggest programs such as OffMaps, Navfree and Galileo to get around. By downloading these in advance, you’ll be able to chart a course even without cell service.”

Another important thing to consider is transportation. While mobile apps make it easy to produce digital copies of train and airport tickets, having printed version is still recommended to make sure that a copy of the ticket is available at all times. To make it easier to find airport terminals, having a printed airport layout can also be helpful.

Finally, the report suggests being ready to ask the locals for directions using nothing more than gestures and, if necessary, a notepad.

The latest report is part of Andrew M. Berke’s commitment to offering high-quality travel resources for anyone interested in experiencing the perfect vacation.

Interested parties can find more information by visiting the above-mentioned website.

Contact Info:
Name: Andrew Berke
Organization: Red Rock Growth, LLC
Address: 5712 Tortoise Place, Apollo Beach, FL 33572, United States
Website: http://andrew-m-berke.com/

Source: PressCable

Release ID: 495757

Pressure BioSciences Names the Vogel Laboratory at New York University’s Center for Genomics and Systems Biology a Center of Excellence

Collaboration with Dr. Christine Vogel and Colleagues in NYU’s Internationally Recognized “Hub of Science” Center Will Provide Scientists Immediate Access to PBI’s Innovative and Proprietary Pressure-Based Platform Technologies

SOUTH EASTON, MA / ACCESSWIRE / March 27, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences and other industries, today announced the establishment of a Center of Excellence (“CoE”) at Dr. Christine Vogel’s laboratory at New York University (“NYU”)’s Center for Genomics and Systems Biology (the “GSB Center”).

As a Center of Excellence, the Vogel Lab will have free use of the Company’s primary instrument system, the Barocycler 2320EXTREME (the “2320EXT”) until the end of 2020. They will also be offered early access to new, modified, and/or improved versions of the 2320EXT instrument and its associated applications during the collaboration period. Finally, they will have the opportunity to work closely with PBI’s senior science and engineering staff on new developments in the Company’s pressure-based technology platforms.

Dr. Christine Vogel, an Associate Professor and internationally recognized scientist with multiple publications and awards, is an expert in the field of proteomics (the study of proteins), with special emphasis on protein expression patterns and their relationship to human disease – such as cancer. Dr. Vogel’s laboratory uses state-of-the-art equipment and methods to investigate these and other important properties of proteins, and their association with human disease. As part of the CoE, Dr. Vogel and colleagues, along with students and visitors to the GSB Center, will use PBI’s patented pressure cycling technology™ (“PCT”) platform to help in the development and validation of protocols for tissue-based protein studies that might eventually be used in a clinical setting. In addition, the Vogel laboratory will be open by invitation to local, national, and international scientists for workshops and seminars on the use of the PCT platform in the discovery, identification, and elucidation of proteins that may be involved in human disease.

Ms. Roxana McCloskey, PBI’s Global Director of Sales and Marketing, said: “The innovative 2320EXT intrument is based on PBI’s patented and enabling PCT platform. The 2320EXT is currently used by research scientists worldwide for the safe, rapid, and reproducible lysis of cells and tissues, to release proteins and other important biomolecules (e.g., DNA, RNA, lipids) for analysis. Such analyses are a critical step in the discovery and development of diagnostic, prognostic, and predictive clinical tests used to identify risk, disease presence, or disease progression, and to guide treatment in many diseases, such as cancer.”

Professor Vogel commented: “My laboratory uses the most advanced technologies available to investigate the regulation of proteins in different systems in response to environmental stress. We continually look for powerful, cutting-edge tools to help us reach the highest level of quality possible in our research.”

Dr. Bradford A. Young, Chief Commercial Officer of PBI, said: “We are pleased to have the opportunity to collaborate with Professor Christine Vogel, a well-respected thought leader in proteomics. We believe the 2320EXT has the potential to support and advance the exciting work that she and her team already have underway at the GSB Center. We further believe that the added exposure received by the PCT platform during the collaboration period will increase awareness of the benefits of our pressure-based technologies in helping to provide scientists with superior proteomic analyses. We believe this added awareness should result in increased products and services revenue in 2019 and beyond.”

About the NYU Center for Genomics and Systems Biology

The NYU Center for Genomics and Systems Biology is considered by many as a “hub of science” in New York City. It has state-of-the-art “loft laboratories” where scientists including professors, researchers, and students interact to leverage the extraordinary potential of genomics and systems biology in research and education. This involves the combined skills of genomic, computational, and evolutionary biologists. Faculty also collaborate with researchers in other departments and schools at NYU, such as Physics, Chemistry, Medicine, Engineering, and Global Public Health, as well as with researchers from other major institutions in New York and around the world. The intellectual synergisms brought about by these internal and external collaborations, enable us to develop unique approaches to genomics and systems biology. Working with organisms from all the major branches of the tree of life, researchers at the Center address how genomes encode regulatory genetic networks, respond to changes in the environment or during development, how genes evolve, and how this generates diversity within and across species. These principles are being applied to global questions in human health, food sustainability, bio-energy, and the environment.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, we are actively expanding the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired protein disaggregation and refolding technology from BaroFold, Inc. to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (UST™) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, please visit: www.pressurebiosciences.com

Forward-Looking Statements

This press release contains forward-looking statements. These statements relate to future events or the Company’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the Company’s industry results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors can identify these forward-looking statements by words or phrases such as ”may,” “will,” “except,” “anticipate,” ”aim,””estimate,””intend,””plan,””believe,””is/are likely to,””future” or other similar expressions. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy, and financial needs. These statements are only predictions based on the Company’s current expectations and projections about future events. Investors should not place undue reliance on these statements. In evaluating these statements, Investors should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause the Company’s actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report and other reports filed from time to time with the Securities & Exchange Commission (SEC). More detailed information about these risk factors are set forth in the Company’s filings with the SEC. The Company encourages Investors to review these risk factors. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law. For more information about the Companies, please click on the following website link:

http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:

Richard T. Schumacher, President and CEO (508) 230-1828 (T)

Bradford A. Young, Ph.D., SVP and Chief Commercial Officer (508) 230-1829 (F)

SOURCE: Pressure BioSciences, Inc.

ReleaseID: 540291

Adams 2019 Streamlines Vehicle Dynamics Simulation and Expands Its Real-Time Capabilities

NEWPORT BEACH, CA / ACCESSWIRE / March 27, 2019 / MSC Software Corporation, a global leader in simulation software and services, today announced that it has expanded its groundbreaking virtual prototyping capabilities with enhancements to Adams, its flagship solution for Multi-Body Dynamics simulations in release 2019. Key highlights of this release include the expanded capabilities in Adams Car, the gold standard for automotive vehicle dynamics simulations. With Adams Car, engineering teams can quickly build and test functional virtual prototypes of complete vehicles and vehicle subsystems. Based on user feedback from multiple automotive OEMs around the world, additional vehicle events and new off-the-shelf vehicle templates have been introduced into Adams Car to improve its modeling efficiency in this release.

Adams 2019 also contains new capabilities to streamline workflows in Adams Car and increase user productivity – for example, the addition of event sets, a customizable collection of vehicle dynamics events. These can be leveraged across projects and team members delivering consistent vehicle test methods to avoid duplication of work. The release also introduces a new fast solving, simplified flexible body modeling method. Users can leverage this method for rapid parametric explorations of their design space. Jesper Slattengren, Technical fellow at Pratt and Miller Engineering, said of this release that ”The new features in Adams Car in the 2019 release are major improvements and will have a huge impact on Chassis development and simulation at Pratt and Miller.”

Continuing MSC Software’s focus on real-time simulations, Adams 2019 now enables support for running simulations on the dSPACE® real-time environment. Users of dSPACE SCALEXIO® can now co-simulate with Adams, unlocking opportunities for combining virtual and physical testing to shorten development cycles. Running Adams simulations on dSPACE SCALEXIO® makes it possible to conduct real-time software in the loop (SIL) and hardware in the loop (HIL) scenarios, supporting the development of ADAS and Autonomous Driving systems.

”Streamlining the Adams Car environment in Adams 2019 has been a goal of this release along with expansion of support for real-time simulations,” said Paulo Guglielmini, CEO of MSC software. ”It constitutes a significant step forward in our journey to help Adams users make better vehicle design decisions, faster. We constantly work with automotive OEMs directly and enable them to incorporate their engineering workflows into our product, and that’s why Adams remains the world’s leading multibody dynamics software for over 30 years.”

About MSC Software

MSC Software is one of the ten original software companies and a global leader in helping product manufacturers to advance their engineering methods with simulation software and services. As a trusted partner, MSC Software helps companies improve quality, save time, and reduce costs associated with design and test of manufactured products. Academic institutions, researchers, and students employ MSC’s technology to expand individual knowledge as well as expand the horizon of simulation. MSC Software employs 1,400 professionals in 23 countries. For more information about MSC Software’s products and services, please visit: https://www.mscsoftware.com

MSC Software is part of Hexagon (Nasdaq Stockholm: HEXA B; hexagon.com), a leading global provider of information technology solutions that drive productivity and quality across geospatial and industrial landscapes.

The MSC Software corporate logo and MSC are trademarks or registered trademarks of MSC Software Corporation and/or its subsidiaries in the United States and/or other countries. NASTRAN is a registered trademark of NASA. All other brand names, product names, or trademarks belong to their respective owners.

SOURCE: MSC Software

ReleaseID: 540279

Uptick Newswire Hosts Image Protect, Inc. on The Stock Day Podcast to Discuss the Launch of An All-New In-Image Ad Platform

PHOENIX, AZ / ACCESSWIRE / March 27, 2019 / Uptick Newswire Stock Day Podcast welcomed Image Protect, Inc. (OTC PINK: IMTL) (”the Company”), a company that protects and monetizes creative works. CEO, Matt Goldman, joined host Everett Jolly as a new guest on the Stock Day Podcast.

To begin the interview, Jolly asked Mr. Goldman to share a bit of background information about Image Protect. Mr. Goldman explained that the Company is backed by an experienced management team and works to protect the rights of images, while also monetizing their collection through in-image advertising. The Company achieved year over year revenue but eventually hit a glass ceiling due to a rapidly shrinking industry. With the advent of our Fotofy technology, it enabled The Company to expand into new sectors, such as the high-growth In-Image Advertising Global market.

Jolly asked about the Company’s recent press release that announced the launch of a new digital image marketplace (fotofy.com) that allows users to download beautiful images for free, which are then tracked and monetized via in-image ads as the image is re-shared across the Internet. Mr. Goldman explained that previous to this new Fotofy technology, the company had witnessed extreme growth, but eventually saw the need to expand their services into new markets. The Fotofy technology is the first of its kind within the digital licensing space.

Mr. Goldman explained that this shift in business model offers increased efficiency in terms of sales and overall activity, while also moving Image Protect into the ad-tech space, which is said to reach over $400bn by 2025. Mr. Goldman shared his enthusiasm for the potential of this industry and what it means for the future of the Company.

Jolly then asked if Image Protect will see increased revenues in 2019 as they shift into the In-image Ad sector. Mr. Goldman explained that they do expect increased revenue for 2019, however, the revenue is based on the monetization of their ad platform, which will likely begin in late 2019 as they continue to implement their new business model.

To close the interview, Mr. Goldman shared his enthusiasm for the massive changes they are implementing within the ad-tech space and stated that their new Fotofy.com platform will launch in August of this year.

To hear Matt Goldman’s entire interview, follow the link to the podcast here: https://upticknewswire.com/featured-interview-ceo-matt-goldman-of-image-protect-inc-otcpink-imtl/

Investors Hangout is a proud sponsor of ”Stock Day,” and Uptick Newswire encourages listeners to visit the company’s message board at https://investorshangout.com/

About Image Protect

Image Protect protects and monetizes creative works. By uniting technology with a team of copyright experts, we ensure that content providers preserve the value of their digital assets. Our web application monitors the global Internet to seek and collect evidence for illegally used visual content. Then our legal partners across North America, Europe, and Asia ensure our clients receive appropriate compensation for work used without valid license.

Safe Harbor Provision

Cautionary statement for purposes of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995: Information in this news release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of the Company and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks, uncertainties and assumptions include the execution and performance of contracts by the Company and its customers, suppliers and partners. The Company disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise.

Press & Media Inquiries:

EHC Branding Agency
Info@EHCBrandingAgency.com
(626) MJ-BRAND

Corporate Contact:
Image Protect
Lawrence Adams
larry.adams@imageprotect.com

About Uptick Newswire and the ”Stock Day” Podcast

Founded in 2013, Uptick Newswire is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Uptick provides companies with customized solutions to their news distribution in both national and international media outlets. Uptick is the sole producer of its ”Stock Day” Podcast, which is the number one radio show of its kind in America. The Uptick Network ”Stock Day” Podcast is an extension of Uptick Newswire, which recently launched its Video Interview Studio located in Phoenix, Arizona.

Uptick Newswire Contact:

602-441-3474
https://upticknewswire.com/

SOURCE: Uptick Newswire

ReleaseID: 540261

Tapinator Announces 2018 Financial Results

2018 Full Year Revenues of $2.9 Million and Adjusted EBITDA of $133,000

Net Cash Provided By Operating Activities of $320k, up from $275k in 2017

NEW YORK, NY / ACCESSWIRE / March 27, 2019 / Tapinator, Inc. (OTCQB: TAPM), a developer and publisher of category leading apps for mobile platforms, today announced financial results for the period ended December 31, 2018, and the filing of its annual report and audited financial statements for the years ended December 31, 2018 and 2017. The annual report and audited financial statements may be found at http://www.sec.gov. The results provided below replaces, in its entirety, any guidance or projections previously issued by the Company.

For the year ended December 31, 2018, Tapinator achieved revenue of approximately $2.87 million, bookings* of $3.34 million, net loss of approximately $3.0 million, adjusted EBITDA* of approximately $132,000, and net cash provided by operating activities of approximately $341,000 representing year-over-year changes of -9%, -5%, 19%, -47% and 24%, respectively. For the quarter ended December 31, 2018, Tapinator achieved revenue of approximately $.57 million, bookings* of $.65 million, net loss of approximately $.92 million, adjusted EBITDA* of approximately -$10,000, and net cash provided by operating activities of approximately $28,000 representing year-over-year changes from the 2017 fourth quarter of -34%, -26%, -19%, -109% and -85%, respectively. As of December 31, 2018, Tapinator had cash balances of approximately $871,000, representing a year-over year increase of 253%.

*A table has been included in this press release with non-GAAP adjustments to the Company’s revenue resulting in bookings (a non-GAAP measure) and non-GAAP adjustments to the Company’s net loss, resulting in positive adjusted EBITDA (a non-GAAP measure) for the relevant periods.

Financial Highlights

Three Months Ended

Twelve Months Ended

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2018

Dec. 31, 2017

GAAP Results:

Revenue

$568,580

$858,683

$2,872,276

$3,141,360

Net Loss

($915,603)

($767,262)

($2,996,533)

($3,690,147)

Diluted Net Loss Per Share

($0.01)

($0.01)

($0.03)

($0.06)

Cash

$871,312

$246,755

$871,312

$246,755

Net Cash Provided by Operating Activities

$27,543

$188,934

$341,153

$274,867

Non-GAAP Results:

Bookings:

$653,315

$880,680

$3,341,014

$3,498,788

Category Leading Apps

$363,039

$291,463

$1,699,986

$1,279,574

Rapid-Launch Games

$290,276

$589,217

$1,641,028

$2,219,214

Adjusted EBITDA

($10,444)

$120,915

$132,615

$247,996

Ilya Nikolayev, CEO of Tapinator commented, “2018 represented a challenging, but pivotal year for the Company. We completed our shift from our legacy Rapid-Launch
Games to the more lucrative Category Leading
Apps opportunity (f/k/a “Full-Featured Games”). While this shift took longer than we had originally hoped, and resulted in what we believe to have been only a temporary pause in our overall growth, our strategy has yielded positive results in that our Category Leading Apps
Bookings increased by 33% in 2018 as compared to 2017 and, for the first time, surpassed our Rapid-Launch Games in terms of overall contribution. Looking forward to 2019, we are very enthused about our prospects given our portfolio of existing and planned Category
Leading Apps. We believe these select apps provide both repeatable, stackable revenue and significant growth opportunity through focused marketing and continued product development.

Andrew Merkatz, President & CFO of Tapinator, also commented on the Company’s results, “We are especially proud of the following accomplishments in 2018:

We completed a fully-subscribed private placement of common stock at $.12 per share for which we received net proceeds of $2,581,787,
We eliminated the Company’s outstanding debt, in its entirety,
We eliminated the Company’s outstanding preferred stock, in its entirety,
We executed cost effective product experimentation in the nascent blockchain gaming market,
We completed our previously announced pivot from legacy Rapid Launch Games to Category Leading Mobile Apps,
We reported positive adjusted EBITDA positive results for the 5th year in a row, and we have reported positive adjusted EBITDA every year since the Company’s inception,

We repurchased 7,646,446 of our common shares (approximately 8.7% of our then outstanding shares) from one of the Company’s principal shareholders and service providers from our legacy Rapid Launch Games business in exchange for a future revenue share on certain of our Rapid Launch Games,
We launched our first app that relies primarily on subscription based monetization, an area that we believe we will continue to invest in as we strive to improve our earnings quality via repeatable revenue streams,
We achieved an up-listing to the OTCQB, and
We made significant investment in our user acquisition capability as efficient paid marketing is crucial to our Category
Leading Apps strategy.

In 2018, mobile gaming consumer spend exceeded the combined game spending total on home consoles, PC and Macs, and handheld consoles by 20 percent, according to a recently released study by industry research company, App Annie. Tapinator has become a seasoned operator in this massive market, and we believe we are well positioned to deliver strong growth and corporate development in the coming year.”

Current
Outlook

We continue to have conviction regarding our Category Leading Apps business, and therefore for our business in its entirety. The strategic changes we implemented over the past 24 months, shifting from Rapid-Launch Games to Category Leading Apps, now appear to have paid off. While we are not providing specific financial guidance, we are confident in our ability to deliver company-wide revenue and bookings growth in 2019. This growth is expected to be derived from our seasoned franchises such as Video Poker Classic, combined with recently launched titles such as
Crypto Trillionaire and My Horoscope, and from at least one additional title that we have not yet announced, but expect to launch during the second half of 2019.

Beyond our main focus on our core Category Leading Apps business, we will continue to be nimble and opportunistic in terms of new investment opportunities that we believe can both leverage Tapinator’s resources and can deliver significant long-term returns to our shareholders.

*Non-GAAP Financial
Measures

We have provided in this release the non-GAAP financial measures of Bookings and adjusted EBITDA, as a supplement to the measures of Revenue and Operating Income, which are prepared in accordance with United States generally accepted accounting principles (“GAAP”). Management uses Bookings and adjusted EBITDA internally in analyzing our financial results to assess operational performance and liquidity. The presentation of Bookings and adjusted EBITDA is not intended to be considered in isolation or as a substitute for the financial information prepared in accordance with GAAP. We believe that both management and investors benefit from referring to Bookings and adjusted EBITDA in assessing our performance and when planning, forecasting and analyzing future periods. We believe Bookings and adjusted EBITDA are useful to investors because it allows for greater transparency with respect to key financial metrics we use in making operating decisions and because our investors and analysts use them to help assess the health of our business. Below, we have provided reconciliations between our historical and projected Bookings and adjusted EBITDA to the most directly comparable GAAP financial measures below. Some limitations of Bookings and adjusted EBITDA are as follows:

Bookings does not reflect that
we defer and recognize online game revenue over the estimated life of
durable virtual goods;
Adjusted EBITDA does not
include the impact of stock-based expense, impairment of intangible assets
previously acquired, acquisition-related transaction expenses, contingent
consideration fair value adjustments and restructuring expense;
Adjusted EBITDA does not
reflect income tax expense;
Adjusted EBITDA does not
include other income or expense, which includes foreign exchange gains and
losses and interest income or expense;
Adjusted EBITDA excludes
depreciation and amortization of intangible assets and impairment of
capitalized software. Although
depreciation and amortization and impairment of capitalized software are
non-cash charges, the assets being depreciated and amortized or impaired may
have to be replaced in the future; and
Other companies, including companies in our industry,
may calculate adjusted EBITDA differently or not at all, which will reduce
their usefulness as a comparative measure.

Because of these limitations, you should consider Bookings and adjusted EBITDA along with other financial performance measures, including Revenue, Net Income (Loss), Diluted Net Income (Loss) Per Share, Cash Flow from Operations, Operating Income (Loss) and our other financial results presented in accordance with GAAP.

Reconciliation of GAAP
to Non-GAAP Results (unaudited)

Three Months Ended

Twelve Months Ended

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2018

Dec. 31, 2017

Reconciliation of
Revenue to Bookings:

Revenue

$568,580

$858,683

$2,872,276

$3,141,360

Change in deferred revenue

$84,735

$21,997

$468,738

$357,429

Bookings

$653,315

$880,680

$3,341,014

$3,498,788

Three Months Ended

Twelve Months Ended

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2018

Dec. 31, 2017

Reconciliation of Net
Income (Loss) to Adjusted EBITDA:

Net loss

$915,603

$767,262

$2,996,533

$3,690,147

Interest expense, net

($1,109)

$120,034

$132,355

$533,511

Income taxes

$2,651

$2,500

$7,226

$8,973

Impairment of capitalized software

$320,311

$256,310

$320,311

$256,310

Amortization of capitalized software development

$176,974

$166,458

$614,172

$709,615

Depreciation and amortization of other assets

$1,955

$5,175

$9,933

$21,927

Amortization of debt discount

$0

$281,813

$187,876

$1,404,254

Loss On Extinguishment

$0

$0

$0

$830,001

Stock-based expense

$404,375

$55,888

$1,857,274

$173,552

Adjusted EBITDA

($10,444)

$120,915

$132,615

$247,996

About Tapinator

Tapinator Inc. (OTCQB: TAPM) develops and publishes category leading apps for mobile platforms. Tapinator’s library includes over 300 titles that, collectively, have achieved over 450 million mobile downloads, including notable properties such as Video
Poker Classic, Solitaire Dash and Crypto Trillionaire. Tapinator generates revenues through the sale of branded advertising and via consumer transactions, including in-app purchases and subscriptions. Founded in 2013, Tapinator is headquartered in New York, with product development and marketing teams located in North America, Europe and Asia. Consumers can find high-quality mobile entertainment wherever they see the ‘T’ character logo, or at http://tapinator.com.

Forward Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding Tapinator, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “believe,””feel,” “may,” “will,” “expect,” “anticipate,” “estimate,” “intend,” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements include, among other things, our belief that our overall growth has only been temporarily paused, our belief that our Category Leading Apps will provide repeatable, stackable revenue and significant growth opportunity, our belief that we are well positioned to deliver strong growth and corporate development and our expectation that our seasoned franchise apps and recently launched apps will result in revenue and bookings growth in 2019. Forward-looking statements in this release involve substantial risks and uncertainties that could cause the development and monetization of our mobile games, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, our ability to create and develop new, successful and long lasting Category Leading Apps, our ability to penetrate in a meaningful way the mobile gaming app consumer spend market while competing against many larger companies, our ability to continue to drive interest in our seasoned titles such as Video Poker Classic and our new titles such as Crypto Trillionaire and our ability to provide repeatable and stackable revenue through our Category
Leading Apps.. Tapinator undertakes no obligation to update or revise any forward-looking statements. The quoting and trading of the Company’s common stock on the OTC Market Group’s OTC Link quotation system is often thin and characterized by wide fluctuations in trading prices, due to many factors that may have little to do with the Company’s operations or business prospects. As a result, there may be volatility in the market price of the shares of the Company’s common stock for reasons unrelated to operating performance. Moreover, the OTC Market Group’s OTC Link quotation system is not a stock exchange, and trading of securities on it is often more sporadic than trading of securities listed on the NASDAQ Stock market or another securities exchange. Accordingly, stockholders may have difficulty reselling any of their shares. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the Company, please see the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and may be viewed at http://www.sec.gov.

CONTACT:

Tapinator Investor Relations
investor.relations@tapinator.com
914.930.6232

SOURCE: Tapinator Inc.

ReleaseID: 540176

Aytu BioScience Provides Study Update for Spermatogenesis Study of Natesto (R), the Only FDA-Approved, Nasally-Administered Testosterone Treatment

Interim Results Demonstrated Preservation of Sperm Parameters After Six Months of Treatment with Nasally-Administered Natesto Testosterone Gel

Natesto Spermatogenesis Study Presentation Awarded Presidential Citation at ENDO 2019 Scientific Meeting

ENGLEWOOD, CO / ACCESSWIRE / March 27, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs, is providing an enrollment update for the ongoing Natesto Spermatogenesis Study, the Phase 4 clinical trial investigating the impact of nasally-administered Natesto on preservation of fertility parameters. This study is being conducted at the University of Miami’s Department of Urology, and Dr. Ranjith Ramasamy, MD, the Director of Reproductive Urology, is the study’s principal investigator.

To date, 56 patients have been enrolled in the study, and 15 subjects have completed treatment at six months. Interim results published to date demonstrate that all three measured fertility parameters are preserved after three and six months of Natesto treatment.

Additionally, the presentation of the Natesto Spermatogenesis Study was awarded with a Presidential citation at the 101st Annual Endocrine Society Meeting held March 23-26 in New Orleans, LA. Lead author and University of Miami urology chief resident Tom Masterson, MD presented interim data for the ongoing study and received the Presidential citation. The Presidential Poster Competition awards presenting fellows and trainees for research excellence and impact of the research in the field of endocrinology.

The Natesto Spermatogenesis Study is investigating the impact of Natesto, the only FDA approved, nasally-administered testosterone treatment, on sperm production. This single-site, prospective study is evaluating hypogonadal men, ages 18 to 55, completing a six-month treatment period with Natesto to restore clinically low serum testosterone levels with the goal of maintaining sperm concentration, motility, and total motile sperm count.

Of the 56 subjects enrolled to date, 43 subjects have completed one month of Natesto therapy, 23 subjects have completed three months, and 15 subjects have completed the full six-month treatment period equivalent to two rounds of spermatogenesis.

Interim results demonstrate that subjects completing the six-month treatment period not only had serum testosterone levels return to the normal range, but all measures of semen parameters including sperm concentration, sperm motility, and total motile sperm count (TMSC) remained statistically unchanged through three months and six months of therapy.

Traditional testosterone replacement therapy (TRT), as a whole, has been known to decrease gonadotropin levels, diminish sperm production and function, and decrease the natural production of endogenous testosterone in men being treated with TRT. Maintenance of fertility and family planning is an important discussion topic for the more than 2 million men considering testosterone replacement therapy. Therefore, the effect of Natesto possibly minimizing the impact on sperm production would be clinically impactful and novel by providing a safe and effective approach for treating men with hypogonadism.

Josh Disbrow, Aytu BioScience’s Chief Executive Officer commented, ”We congratulate Dr. Masterson, Dr. Ramasamy, and their entire research group for receiving the prestigious Presidential citation at ENDO 2019 for their ongoing work with the Natesto Spermatogenesis Study. Their work surrounding Natesto is exciting, and these data may represent a true paradigm shift in how clinicians treat Low T. We’re encouraged by the positive results to date demonstrating preservation of fertility parameters with Natesto. Further, it is encouraging to see the high level of patient enrollment achieved to date in this novel study. We’re looking forward to observing Dr. Ramasamy’s group’s continued progress with this study and seeing the final results this summer.”

The entire study group is expected to complete the full six-month treatment period during summer 2019, and the full data will be reported soon thereafter.

Interim results were previously published in August 2018 in European Urology Focus.

Aytu BioScience is sponsoring this investigator-initiated trial, and complete details on the study can be found at https://clinicaltrials.gov/ct2/show/NCT03203681?term=Natesto&rank=4

About Aytu BioScience, Inc.

Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs. The company currently markets Natesto®, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or “Low T”). Aytu also has exclusive U.S. and Canadian rights to ZolpiMist™, an FDA-approved, commercial-stage prescription sleep aid indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Aytu recently acquired exclusive U.S. commercial rights to Tuzistra® XR, the only FDA-approved 12-hour codeine-based antitussive. Tuzistra XR is a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an extended-release oral suspension. Additionally, Aytu is developing MiOXSYS®, a novel, rapid semen analysis system with the potential to become a standard of care for the diagnosis and management of male infertility caused by oxidative stress. MiOXSYS is commercialized outside of the U.S. where it is a CE Marked, Health Canada cleared, Australian TGA approved, Mexican COFEPRAS approved product, and Aytu is planning U.S.-based clinical trials in pursuit of 510k de novo medical device clearance by the FDA. Aytu’s strategy is to continue building its portfolio of revenue-generating products, leveraging its focused commercial team and expertise to build leading brands within large, growing markets. For more information visit aytubio.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this presentation, are forward-looking statements. Forward looking statements are generally written in the future tense and/or are preceded by words such as ”may,” ”will,” ”should,” ”forecast,” ”could,” ”expect,” ”suggest,” ”believe,” ”estimate,” ”continue,” ”anticipate,” ”intend,” ”plan,” or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: risks relating to the completion and final results of the Natesto Spermatogenesis Study, gaining market acceptance of our products, obtaining reimbursement by third-party payors, the potential future commercialization of our product candidates, the anticipated start dates, durations and completion dates, as well as the potential future results, of our ongoing and future clinical trials, the anticipated designs of our future clinical trials, anticipated future regulatory submissions and events, our anticipated future cash position and future events under our current and potential future collaboration. We also refer you to the risks described in ”Risk Factors” in Part I, Item 1A of the Company’s Annual Report on Form 10-K and in the other reports and documents we file with the Securities and Exchange Commission from time to time.

Contact for Investors:

James Carbonara
Hayden IR
(646)-755-7412
james@haydenir.com

SOURCE: Aytu BioScience, Inc.

ReleaseID: 540281

The tour of Chinese sanitary ware brand attracting global cooperation

TANGSHANG CHINA / ACCESSWIRE / March 27, 2019 / With 25 years of experience as a manufacturer, IMEX always focus on the sanitary ware industry and with precise and professional working spirit turn itself to be trusted “craftsman.”

It’s indicated from China’s customs statistics that IMEX products have no barriers exporting to 132 countries and have been the top seller to European market since 2013.

Since 2007, IMEX brand has been constantly presented in ISH fair seven years in a row to display its high quality manufactured from China and to convey brand information and creates brand images that can be well trusted from the worldwide.

For the European market, IMEX understands what the consumers there need the most and design the products they prefer. IMEX will always stick to the precise quality from sanitary ware to intelligent toilet and have been proved and widely used in E.U.

IMEX has been working with distributors and serving the European countries for more 20 years. Graham Wickens, the director from IMEX UK said since 2002, when the first container delivered to UK market, the reputation of brand IMEX has been constantly growing based on its high quality products and intimate service. IMEX brand has already won the customers trust in UK.

IMEX is now inviting more partners to join hands together to offer brilliant service and products to Europe.

Brand introduction:

IMEX is a famous sanitary ware brand in China. IMEX not only has the world advanced technique and equipment but also has the senior designers and management team. The factory covers an area of 200,000㎡ and has more than 2,000 staff in total. The capacity is over 2,000,000 piece of sanitary ware and 20,000 sets of bathroom furniture. IMEX product has been exporting to 132 countries and serving more than 500 million users in the world.

Contact us:

Tangshan IMEX Industrial Co., LTD

Add:No. 211 Tianyuanli District, Dali Road, Tangshan, China. (063000)

Tidy Xing

Mob: 0086-15511926576

Email: tidy@imexceramic.com

SOURCE: Tangshan IMEX Industrial Co., LTD

ReleaseID: 540298

Aztec Minerals Confirms Five CRD Target Areas on the Tombstone Property, Arizona by 3-D Modelling of Recent Airborne Magnetic Survey Data

VANCOUVER, CA / ACCESSWIRE / March 27, 2019 / Aztec Minerals Corp.
(AZT: TSX-V, OTCQB: AZZTF) confirms the identification of five prospective, buried CRD target areas on the Tombstone Property, Cochise County, Arizona, USA by 3-D modelling of Aztec’s recent airborne magnetic survey data.

3-dimensional modelling of the airborne magnetic data was undertaken by geophysical consultants CompGeoInc of Vancouver, BC who produced a UBC modeled inversion as well as multiple depth and horizontal slices (link
1
, link 2). This modelling work is very useful in
identifying subsurface massive sulphide CRD (Carbonate Replacement
Deposits) targets or other styles of sulfide mineralization.

Aztec previously identified three target areas based on its recent geological mapping and sampling and analysis of historic exploration and mining data. The new 3-dimensional magnetic modelling confirmed and better defined the potential of the three target areas and identified two more, as follows:

The north-northeast trending Contention Pit area veins and dikes are marked by a linear magnetic high/low contact and appear to extend below the historic mines, which typically bottomed at the water table around 200 metres depth, down into the underlying Paleozoic limestone formations which are similar rocks that host the Taylor zinc-silver-lead CRD deposit of Arizona Mining Inc., subsequently purchased by South32 (located only 65 kilometres west of Tombstone).
A possible south extension of the Contention Pit area, offset 100 meters to the west by a southeast trending cross fault or anticlinal structure
A parallel zone to the Contention Pit approximately 350 meters to the southeast that is mostly covered by thin alluvium thus not explored in historic times, also marked by a linear north-northeast magnetic high/low contact
Two northwest-southeast trending anticlinal structures, marked by a series of weak magnetic highs, host silver-lead-zinc replacements in the Bisbee Group and appear to extend into the underlying Paleozoic limestone formations
A circular magnetic high with a central low occurs at the northern end of the Contention Pit, possibly separate from the dikes and veins, and could represent a pipe-like feature related to limestone dissolution and collapse, ideal for the development of CRD’s

Now that the main prospective structures have been defined, a natural source, AMT (audio-frequency magneto-tellurics) geophysical survey is being planned over the property to map resistivity and conductivity contrasts in the subsurface sedimentary rocks. Any high conductivity/low resistivity anomalies could represent buried carbonate replacement deposits (CRD’s) and massive sulphide deposits.

Pursuant to the option agreement with Baroyeca Gold and Silver Inc., Aztec has exceeded the first year expenditure requirements and anticipates entering into the second year of the option agreement by the March 23, 2019 anniversary date.

QP Disclosure – The geophysical data was used in raw form by consulting company CompGeoInc who applied filtering to smooth the cultural interference and then produced a 3-dimensional model using University of British Columbia (UBC) open source software. Joey Wilkins, P.G., is the QP and CEO/President of Aztec Minerals Corp and has approved the use of this data for news release and interpretation.

About Aztec Minerals – Aztec is a mineral exploration company focused on the discovery of large deposits in the Americas. Our core asset is the prospective Cervantes porphyry gold-copper property in Sonora, Mexico, where the company can acquire 100%. Further information on the option to purchase can be found on our website. Our district-scale historic Tombstone properties hold both bulk tonnage epithermal gold-silver as well as CRD silver-lead-zinc deposits in Cochise County, Arizona. Aztec’s shares trade on the TSX-V stock exchange (symbol AZT) and on the OTCQB (symbol AZZTF).

Contact Information – For more information, please contact:
Neil MacRae, Vice President, Investor Relations
Tel: (604) 685-9770
Fax: (604) 685-9744
Email: neil@aztecminerals.com
Website: www.aztecminerals.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Cautionary Note Regarding Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking statements and information herein include but are not limited to statements regarding Aztec’s anticipated performance in 2018 and the future, including the exercise of the options on the Cervantes and Tombstone properties, the planned exploration activities, receipt of assay results from drilling, the completion of further drilling and exploration work, and the timing and results of various activities. The Company does not intend to, and does not assume any obligation to update such forward-looking statements or information, other than as required by applicable law.

Forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Aztec and its operations to be materially different from those expressed or implied by such statements. Such factors include, among others, changes in national and local governments, legislation, taxation, controls, regulations and political or economic developments in Canada and the United States; financial risks due to precious and base metals prices, operating or technical difficulties in mineral exploration, development and mining activities; risks and hazards of mineral exploration, development and mining; the speculative nature of mineral exploration and development, risks in obtaining necessary licenses and permits, and challenges to the Company’s title to properties.

Forward-looking statements are based on assumptions management believes to be reasonable, including but not limited to the continued operation of the Company’s exploration operations, no material adverse change in the market price of commodities, and such other assumptions and factors as set out herein. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or information, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed or intended. There can be no assurance that any forward-looking statements or information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information.

SOURCE: Aztec Minerals Corp.

ReleaseID: 540274

Kontrol Energy Launches US and European Institutional Investor Roadshow

TORONTO, ON / ACCESSWIRE / March 27, 2019 / Kontrol Energy Corp. (CSE: KNR, OTCQB: KNRLF, FSE:1K8) (“Kontrol” or “Company”) announces that it will conduct a series of investor meetings in the US and Europe from April 2nd through April 19th.

The Company is embarking on an introduction campaign through multiple US and European cities during the month of April and will present to institutional funds, family offices and brokers. The roadshow will support the Company’s stated efforts to ramp up business in the US and create awareness of Kontrol’s February 13, 2019 US listing on the OTCQB and its recent submission for DTC trading eligibility.

Paul Ghezzi, CEO of Kontrol Energy stated: “As we gear up to commit more operational efforts to the US in 2019, it is essential for us to get in front of the investment community and share the Kontrol growth story.” Mr. Ghezzi continued: “We firmly believe that all the necessary groundwork has been laid to capitalize on building our US institutional shareholder base.”

If you are an institutional investor based in or around New York City and are interested in a meeting with management please reach out to Jonathan.Paterson@HarborAccessLLC.com

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy was recently announced as the 7th fastest growing Startup in Canada by Canadian Business and Maclean’s.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

For further information, contact us at admin@kontrolenergy.com Kontrol Energy Corp., 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123

For further information, contact:

Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

Certain information included in this press release, including information relating to future financial or operating performance and other statements that express the expectations of management or estimates of future performance constitute “forward-looking statements”. Such forward-looking statements include, without limitation, statements regarding the Offering, possible future acquisitions and/or investments in operating businesses and/or technologies, accelerated organic growth, the provision of solutions to customers and greenhouse gas emissions reductions, proposed financial savings and sustainable energy benefits and energy monitoring. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that the Offering will be successful, that suitable businesses and technologies for acquisition and/or investment will be available, that such acquisitions and or investment transactions will be concluded, that sufficient capital will be available to the Company, that technology will be as effective as anticipated, that organic growth will occur, and others. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to, lack of acquisition and investment opportunities or that such opportunities may not be concluded on reasonable terms, or at all, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Kontrol Energy Corp.

ReleaseID: 540283